Literature DB >> 20197555

Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.

Niccolò Bolli1, Elspeth M Payne, Clemens Grabher, Jeong-Soo Lee, Adam B Johnston, Brunangelo Falini, John P Kanki, A Thomas Look.   

Abstract

Mutations in the human nucleophosmin (NPM1) gene are the most frequent genetic alteration in adult acute myeloid leukemias (AMLs) and result in aberrant cytoplasmic translocation of this nucleolar phosphoprotein (NPMc+). However, underlying mechanisms leading to leukemogenesis remain unknown. To address this issue, we took advantage of the zebrafish model organism, which expresses 2 genes orthologous to human NPM1, referred to as npm1a and npm1b. Both genes are ubiquitously expressed, and their knockdown produces a reduction in myeloid cell numbers that is specifically rescued by NPM1 expression. In zebrafish, wild-type human NPM1 is nucleolar while NPMc+ is cytoplasmic, as in human AML, and both interact with endogenous zebrafish Npm1a and Npm1b. Forced NPMc+ expression in zebrafish causes an increase in pu.1(+) primitive early myeloid cells. A more marked perturbation of myelopoiesis occurs in p53(m/m) embryos expressing NPMc+, where mpx(+) and csf1r(+) cell numbers are also expanded. Importantly, NPMc+ expression results in increased numbers of definitive hematopoietic cells, including erythromyeloid progenitors in the posterior blood island and c-myb/cd41(+) cells in the ventral wall of the aorta. These results are likely to be relevant to human NPMc+ AML, where the observed NPMc+ multilineage expression pattern implies transformation of a multipotent stem or progenitor cell.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197555      PMCID: PMC2858496          DOI: 10.1182/blood-2009-02-207225

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants.

Authors:  David Traver; Barry H Paw; Kenneth D Poss; W Todd Penberthy; Shuo Lin; Leonard I Zon
Journal:  Nat Immunol       Date:  2003-11-09       Impact factor: 25.606

2.  Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling.

Authors:  Ulrike Langheinrich; Elisabeth Hennen; Gordon Stott; Gabi Vacun
Journal:  Curr Biol       Date:  2002-12-10       Impact factor: 10.834

3.  The syntenic relationship of the zebrafish and human genomes.

Authors:  W B Barbazuk; I Korf; C Kadavi; J Heyen; S Tate; E Wun; J A Bedell; J D McPherson; S L Johnson
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

4.  UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA.

Authors:  Ming H Wu; Benjamin Y M Yung
Journal:  J Biol Chem       Date:  2002-10-08       Impact factor: 5.157

5.  tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors.

Authors:  Stéphane Berghmans; Ryan D Murphey; Erno Wienholds; Donna Neuberg; Jeffery L Kutok; Christopher D M Fletcher; John P Morris; Ting Xi Liu; Stefan Schulte-Merker; John P Kanki; Ronald Plasterk; Leonard I Zon; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

6.  One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.

Authors:  J Gilley; M Fried
Journal:  Oncogene       Date:  2001-11-01       Impact factor: 9.867

7.  Myc-induced T cell leukemia in transgenic zebrafish.

Authors:  David M Langenau; David Traver; Adolfo A Ferrando; Jeffery L Kutok; Jon C Aster; John P Kanki; Shuo Lin; Ed Prochownik; Nikolaus S Trede; Leonard I Zon; A Thomas Look
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

8.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Nucleophosmin regulates the stability and transcriptional activity of p53.

Authors:  Emanuela Colombo; Jean-Christophe Marine; Davide Danovi; Brunangelo Falini; Pier Giuseppe Pelicci
Journal:  Nat Cell Biol       Date:  2002-07       Impact factor: 28.824

10.  Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.

Authors:  Maggie L Kalev-Zylinska; Julia A Horsfield; Maria Vega C Flores; John H Postlethwait; Maria R Vitas; Andrea M Baas; Philip S Crosier; Kathryn E Crosier
Journal:  Development       Date:  2002-04       Impact factor: 6.868

View more
  38 in total

Review 1.  Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.

Authors:  Nicholas R Harrison; Fabrice J F Laroche; Alejandro Gutierrez; Hui Feng
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  A tale of two genes: a new connection between NIPBL and NPM1 in acute myeloid leukemia.

Authors:  Elizabeth A R Garfinkle; Tanja A Gruber
Journal:  Haematologica       Date:  2019-07       Impact factor: 9.941

Review 3.  Is acute myeloid leukemia a liquid tumor?

Authors:  Maro Ohanian; Stefan Faderl; Farhad Ravandi; Naveen Pemmaraju; Guillermo Garcia-Manero; Jorge Cortes; Zeev Estrov
Journal:  Int J Cancer       Date:  2013-02-04       Impact factor: 7.396

4.  Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML.

Authors:  Elspeth M Payne; Niccolò Bolli; Jennifer Rhodes; Omar I Abdel-Wahab; Ross Levine; Cyrus V Hedvat; Richard Stone; Arati Khanna-Gupta; Hong Sun; John P Kanki; Hanna T Gazda; Alan H Beggs; Finbarr E Cotter; A Thomas Look
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

5.  Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.

Authors:  Fei-Fei Li; Sha Yi; Lu Wen; Jing He; Li-Jing Yang; Jie Zhao; Ben-Ping Zhang; Guo-Hui Cui; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06       Impact factor: 6.150

6.  Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.

Authors:  Ramesh Balusu; Warren Fiskus; Rekha Rao; Daniel G Chong; Srilatha Nalluri; Uma Mudunuru; Hongwei Ma; Lei Chen; Sreedhar Venkannagari; Kyungsoo Ha; Sunil Abhyankar; Casey Williams; Joseph McGuirk; Hanna Jean Khoury; Celalettin Ustun; Kapil N Bhalla
Journal:  Blood       Date:  2011-06-30       Impact factor: 22.113

Review 7.  Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.

Authors:  P Sportoletti; E Varasano; R Rossi; A Mupo; E Tiacci; G Vassiliou; M P Martelli; B Falini
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

8.  Adaptation to low parasite abundance affects immune investment and immunopathological responses of cavefish.

Authors:  Robert Peuß; Andrew C Box; Shiyuan Chen; Yongfu Wang; Dai Tsuchiya; Jenna L Persons; Alexander Kenzior; Ernesto Maldonado; Jaya Krishnan; Jörn P Scharsack; Brian D Slaughter; Nicolas Rohner
Journal:  Nat Ecol Evol       Date:  2020-07-20       Impact factor: 15.460

9.  Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.

Authors:  Koji Ando; Hideki Tsushima; Emi Matsuo; Kensuke Horio; Shinya Tominaga-Sato; Daisuke Imanishi; Yoshitaka Imaizumi; Masako Iwanaga; Hidehiro Itonaga; Shinichiro Yoshida; Tomoko Hata; Ryozo Moriuchi; Hitoshi Kiyoi; Stephen Nimer; Hiroyuki Mano; Tomoki Naoe; Masao Tomonaga; Yasushi Miyazaki
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

10.  Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemia.

Authors:  Bai-Liang He; Xiangguo Shi; Cheuk Him Man; Alvin C H Ma; Stephen C Ekker; Howard C H Chow; Chi Wai Eric So; William W L Choi; Wenqing Zhang; Yiyue Zhang; Anskar Y H Leung
Journal:  Blood       Date:  2014-03-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.